The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Esfandiari, E.
Right arrow Articles by Liew, F. Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Esfandiari, E.
Right arrow Articles by Liew, F. Y.
The Journal of Immunology, 2001, 167: 5338-5347.
Copyright © 2001 by The American Association of Immunologists

A Proinflammatory Role of IL-18 in the Development of Spontaneous Autoimmune Disease1

Ehsanollah Esfandiari2,*, Iain B. McInnes{dagger}, George Lindop{ddagger}, Fang-Ping Huang3,*, Max Field{dagger}, Mousa Komai-Koma*, Xiao-qing Wei* and Foo Y. Liew4,*

* Department of Immunology and Bacteriology, {dagger} Centre of Rheumatic Disease and {ddagger} Department of Pathology, University of Glasgow, Glasgow, United Kingdom

Serum from patients with systemic lupus erythematosus (SLE) contained significantly higher concentrations of IL-18 than normal individuals. MRL/lpr mice, which develop spontaneous lupus-like autoimmune disease, also had higher serum levels of IL-18 than wild-type MRL/++ mice. Daily injections of IL-18 or IL-18 plus IL-12 resulted in accelerated proteinuria, glomerulonephritis, vasculitis, and raised levels of proinflammatory cytokines in MRL/lpr mice. IL-18-treated MRL/lpr mice also developed a "butterfly" facial rash resembling clinical SLE. In contrast, MRL/lpr mice treated with IL-18 plus IL-12 did not develop a facial rash. The facial lesion in the IL-18-treated mice showed epidermal thickening with intense chronic inflammation accompanied by increased apoptosis, Ig deposition, and early systemic Th2 response compared with control or IL-12 plus IL-18-treated mice. These data therefore show that IL-18 is an important mediator of lupus-like disease and may thus be a novel target for therapeutic intervention of spontaneous autoimmune diseases.




This article has been cited by other articles:


Home page
Infect. Immun.Home page
M. Lochner, K. Kastenmuller, M. Neuenhahn, H. Weighardt, D. H. Busch, W. Reindl, and I. Forster
Decreased Susceptibility of Mice to Infection with Listeria monocytogenes in the Absence of Interleukin-18
Infect. Immun., September 1, 2008; 76(9): 3881 - 3890.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
Y-J. Lin, L. Wan, J.-C Sheu, C-M. Huang, C-W. Lin, Y-C. Lan, C-H. Lai, C-H. Hung, Y. Tsai, C-H. Tsai, et al.
A/C polymorphism in the interleukin-18 coding region among Taiwanese systemic lupus erythematosus patients
Lupus, February 1, 2008; 17(2): 124 - 127.
[Abstract] [PDF]


Home page
J. Leukoc. Biol.Home page
D. Montufar-Solis, H.-C. Wang, and J. R. Klein
Stimulatory and costimulatory effects of IL-18 directed to different small intestinal CD43 T cell subsets
J. Leukoc. Biol., November 1, 2007; 82(5): 1166 - 1173.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
D. Neumann, T. Tschernig, D. Popa, A. Schmiedl, G. P. de Lema, K. Resch, and M. U. Martin
Injection of IL-12- and IL-18-encoding plasmids ameliorates the autoimmune pathology of MRL/Mp-Tnfrsf6lpr mice: synergistic effect on autoimmune symptoms
Int. Immunol., December 1, 2006; 18(12): 1779 - 1787.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
M. C. Park, S. W. Lee, Y. B. Park, and S. K. Lee
Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis
Rheumatology, May 1, 2006; 45(5): 545 - 548.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
L. Bao, I. Osawe, M. Haas, and R. J. Quigg
Signaling through Up-Regulated C3a Receptor Is Key to the Development of Experimental Lupus Nephritis
J. Immunol., August 1, 2005; 175(3): 1947 - 1955.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Kinoshita, T. Yamagata, Y. Nozaki, M. Sugiyama, S. Ikoma, M. Funauchi, and A. Kanamaru
Blockade of IL-18 Receptor Signaling Delays the Onset of Autoimmune Disease in MRL-Faslpr Mice
J. Immunol., October 15, 2004; 173(8): 5312 - 5318.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
H. Oku, Y. Tsuji, S.-I. Kashiwamura, S. Adachi, A. Kubota, H. Okamura, and K. Koyama
Role of IL-18 in pathogenesis of endometriosis
Hum. Reprod., March 1, 2004; 19(3): 709 - 714.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
P. Bossu, D. Neumann, E. Del Giudice, A. Ciaramella, I. Gloaguen, G. Fantuzzi, C. A. Dinarello, E. Di Carlo, P. Musiani, P. L. Meroni, et al.
IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease
PNAS, November 25, 2003; 100(24): 14181 - 14186.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. Kikawada, D. M. Lenda, and V. R. Kelley
IL-12 Deficiency in MRL-Faslpr Mice Delays Nephritis and Intrarenal IFN-{gamma} Expression, and Diminishes Systemic Pathology
J. Immunol., April 1, 2003; 170(7): 3915 - 3925.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Komai-Koma, J. A. Gracie, X.-q. Wei, D. Xu, N. Thomson, I. B. McInnes, and F. Y. Liew
Chemoattraction of Human T Cells by IL-18
J. Immunol., January 15, 2003; 170(2): 1084 - 1090.
[Abstract] [Full Text] [PDF]


Home page
Int ImmunolHome page
M. Abraham, S. Shapiro, N. Lahat, and A. Miller
The role of IL-18 and IL-12 in the modulation of matrix metalloproteinases and their tissue inhibitors in monocytic cells
Int. Immunol., December 1, 2002; 14(12): 1449 - 1457.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.